What if the next big breakthrough in healthcare isn’t a new drug… but a smarter way to manufacture every drug?

In this episode of Savage Angel, Angela sits down with Ben Davis, serial entrepreneur and CEO of Phizzle—a company bringing automation and data integrity to pharmaceutical manufacturing by digitizing and remotely operating critical “everyday workhorse” lab instruments.

Ben shares the wild behind-the-scenes reality of how much pharma still relies on manual workflows (yes, including paper), why that creates risk and costly delays, and how Phizzle’s platform helps manufacturers improve compliance, reduce operational waste, and move faster—without sacrificing precision.

You’ll also hear Ben’s founder journey: from building and selling a mobile gaming company, to launching Phizzle in 2005, to making a major pivot in 2019 that positioned the company for its current mission in pharma.

What You’ll Learn

• Why pharma manufacturing is still one of the most manual + heavily regulated industries on the planet—and what that means for cost and speed
• What “data integrity” really means in regulated environments (and why it’s non-negotiable)
• How automating instrument workflows can reduce errors, protect batches, and accelerate time-to-market
• The “big pivot” Ben made in 2019—and how Phizzle repositioned into pharma automation
• The bigger vision: what automation unlocks as the industry moves toward more advanced therapies

🔗 Connect with Ben Davis / Phizzle
🌐 Website: Phizzle
▶️ YouTube: Phizzle